Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM

被引:4
|
作者
Aniji, M. [1 ]
Kavitha, N. [2 ]
Balamuralitharan, S. [3 ]
机构
[1] Univ Coll Engn, Pattukkottai 614701, Tamil Nadu, India
[2] Univ Coll Engn, Dept Math, Pattukkottai 614701, Tamil Nadu, India
[3] SRM Inst Sci & Technol, Fac Engn & Technol, Dept Math, Kattankulathur 603203, Tamil Nadu, India
关键词
HBV; Antiviral therapy; LHAM; CTL; Immune; Mathematical modeling; 34G20; 34A34; HBV; TRANSMISSION; DYNAMICS; EPIDEMIOLOGY; VACCINATION; PREVALENCE;
D O I
10.1186/s13662-020-02770-2
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Anti-viral therapy is comparatively very effective for patients who get affected by the hepatitis B virus. It is of prime importance to understand the different relations among the viruses, immune responses and overall health of the liver. In this paper, mathematical modeling is done to analyze and understand the effect of antiviral therapy using LHAM which describes the possible relation to HBV and target liver cells. The numerical simulations and error analysis are done up to a sixth-order approximation with the help of Matlab. This paper analyzes how the number of infected cells largely gets reduced and also how the liver damage can be controlled. Therefore, the treatment is successful for HBV infected patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies
    Zoulim, F
    ANTIVIRAL RESEARCH, 1999, 44 (01) : 1 - 30
  • [22] Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection
    Han, YX
    Xue, R
    Zhao, W
    Zhou, ZX
    Li, JN
    Chen, HS
    Chen, XH
    Wang, YL
    Li, YH
    Wu, YW
    You, XF
    Zhao, LX
    Jiang, JD
    ANTIVIRAL RESEARCH, 2005, 68 (03) : 147 - 153
  • [23] Antiviral therapy for hepatitis B virus associated hepatic failure
    Wang, Yu-Ming
    Tang, Ying-Zi
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (01) : 17 - 24
  • [24] Antiviral Therapy in Decompensated Cirrhosis due to Hepatitis B Virus
    Fu, Qingchun
    Chen, Chengwei
    GUT AND LIVER, 2011, 174 : 123 - 126
  • [25] Hepatitis B virus escape mutants induced by antiviral therapy
    Sheldon, Julie
    Soriano, Vincent
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 766 - 768
  • [26] Hepatitis B virus infection in patients presenting for immunosuppressive cancer therapy with and without underlying HIV infection
    Ngoato, Malowane H.
    Amponsah-Dacosta, Edina
    Blose, Ntombifuthi
    Selabe, Selokela G.
    Msibi, Thembeni L.
    Motswaledi, Mojakgomo H.
    Musyoki, Andrew M.
    FRONTIERS IN VIROLOGY, 2023, 3
  • [27] The Changing Demographics of Hepatitis B Virus Infection
    Tout, Issam
    Loureiro, Dimitri
    Asselah, Tarik
    CLINICS IN LIVER DISEASE, 2021, 25 (04) : 673 - 687
  • [28] Antiviral therapy for hepatitis B virus associated hepatic failure
    Yu-Ming Wang and Ying-Zi Tang Institute for Infectious Diseases of PLA
    Hepatobiliary & Pancreatic Diseases International, 2009, 8 (01) : 17 - 24
  • [29] The epidemiology of hepatitis B virus infection in Korea
    Yim, Sun Young
    Kim, Ji Hoon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05) : 945 - 953
  • [30] Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination
    Elrashidy, Heba
    El-Didamony, Gamal
    Elbahrawy, Ashraf
    Hashim, Alaa
    Alashker, Ahmed
    Morsy, Mohamed Hanafy
    Elwassief, Ahmed
    Elmestikawy, Amr
    Abdallah, Abdallah Mahmoud
    Mohammad, Abdel-Gawad Saeid
    Mostafa, Mohamed
    George, Nilly M.
    Abdelhafeez, Hafez
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2336 - 2341